COMP <GO>
AA vs TMO // RSI-14 & 200D SMA MOMENTUM
Alcoa Corporation Common Stock (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AA 8
— TMO 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $39.19 (-1.75%) • MKT CAP: $10.53B
rsi-technicals
37.4
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
rsi-technicals
59.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AA VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AA | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.90% | 9.30% | +6.60 | AA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.9x | 30.4x | -24.50 | AA | /valuation <GO> |
| Free Cash Flow Yield | 5.39% | 2.40% | +2.99 | AA | /fcf-yield <GO> |
| Operating Margin | 11.00% | 17.40% | -6.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 9.00% | 15.10% | -6.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.90% | 3.90% | +4.00 | AA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.99% | 0.24% | +0.75 | AA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.82 | 4.50 | -2.68 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | AA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 37.4 | 59.1 | -21.80 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.94 | +0.02 | AA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.5x | 36.3x | -27.80 | AA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.53B | $262.22B | -$251.69B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AA REV | TMO REV | AA GROSS % | TMO GROSS % | AA FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.83B | $44.56B | 44.0% | 44.0% | $567.0M | $6.29B |
| FY 2024 | $11.89B | $42.88B | 44.0% | 44.0% | $42.0M | $7.27B |
| FY 2023 | $10.55B | $42.86B | 44.0% | 44.0% | -$383.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AA // BETA 0.96
TMO // BETA 0.94